Literature DB >> 10570240

Liver fatty acid binding protein: species variation and the accommodation of different ligands.

J Thompson1, A Reese-Wagoner, L Banaszak.   

Abstract

The crystal structure of rat liver fatty acid binding protein (LFABP) and an alignment of amino acid sequences of all known species have been used to demonstrate two groups or sub-classes. Based on estimates at neutral pH and the electrostatic field calculated using the crystal coordinates, some evidence of changes that occur in going from holo- to apo-forms has been obtained. LFABP belongs to a large family frequently referred to as the intracellular lipid binding proteins or iLBPs. LFABP, unlike other family members, has two fatty acid binding sites. The two cavity sites have been reviewed and arguments for interactions between the sites are presented. Based on the crystal structure of rat LFABP, differences between the A and B groups have been postulated. Last of all, hypothetical models have been built of complexes of LFABP and heme, and LFABP and oleoyl CoA. In both cases, the stoichiometry is one to one and the models show why this is likely.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570240     DOI: 10.1016/s1388-1981(99)00146-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  CASTp: Computed Atlas of Surface Topography of proteins.

Authors:  T Andrew Binkowski; Shapor Naghibzadeh; Jie Liang
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  A nuclear magnetic resonance-based structural rationale for contrasting stoichiometry and ligand binding site(s) in fatty acid-binding proteins.

Authors:  Yan He; Rima Estephan; Xiaomin Yang; Adriana Vela; Hsin Wang; Cédric Bernard; Ruth E Stark
Journal:  Biochemistry       Date:  2011-02-02       Impact factor: 3.162

Review 3.  Intracellular lipid binding proteins of the small intestine.

Authors:  Luis B Agellon; Matthew J Toth; Alan B R Thomson
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

Review 4.  The effect of charge reversal mutations in the alpha-helical region of liver fatty acid binding protein on the binding of fatty-acyl CoAs, lysophospholipids and bile acids.

Authors:  Robert M Hagan; Joanna K Davies; David C Wilton
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

Review 5.  Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease.

Authors:  Rebecca L Smathers; James J Galligan; Benjamin J Stewart; Dennis R Petersen
Journal:  Chem Biol Interact       Date:  2011-02-24       Impact factor: 5.192

Review 6.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

7.  The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates.

Authors:  Gregory G Martin; Avery L McIntosh; Huan Huang; Shipra Gupta; Barbara P Atshaves; Kerstin K Landrock; Danilo Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2013-12-10       Impact factor: 3.162

8.  Modeling fatty acid delivery from intestinal fatty acid binding protein to a membrane.

Authors:  Maja Mihajlovic; Themis Lazaridis
Journal:  Protein Sci       Date:  2007-07-27       Impact factor: 6.725

9.  Fatty Acid Binding Proteins Expressed at the Human Blood-Brain Barrier Bind Drugs in an Isoform-Specific Manner.

Authors:  Gordon S Lee; Katharina Kappler; Christopher J H Porter; Martin J Scanlon; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2015-08-07       Impact factor: 4.200

Review 10.  Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.

Authors:  Friedhelm Schroeder; Avery L McIntosh; Gregory G Martin; Huan Huang; Danilo Landrock; Sarah Chung; Kerstin K Landrock; Lawrence J Dangott; Shengrong Li; Martin Kaczocha; Eric J Murphy; Barbara P Atshaves; Ann B Kier
Journal:  Lipids       Date:  2016-04-27       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.